These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16400393)

  • 21. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
    Patel SB
    Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tablet.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2005 May; 41(5):317-27. PubMed ID: 16082429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ezetimibe (Ezetrol)].
    Scheen AJ
    Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L; Kosoglou T; Cutler DL; Maxwell S; Statkevich P
    Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
    Descamps OS; De Sutter J; Guillaume M; Missault L
    Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ezetimibe: rationale and role in the management of hypercholesterolemia.
    Yatskar L; Fisher EA; Schwartzbard A
    Clin Cardiol; 2006 Feb; 29(2):52-5. PubMed ID: 16506638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
    Davis HR; Veltri EP
    J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia.
    Brown AJ
    Curr Opin Lipidol; 2002 Dec; 13(6):701-3. PubMed ID: 12441896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
    Scheen AJ; Radermecker RP
    Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ezetimibe.
    Harris M; Davis W; Brown WV
    Drugs Today (Barc); 2003 Apr; 39(4):229-47. PubMed ID: 12743640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezetimibe: a novel option for lowering cholesterol.
    Davidson MH
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):11-21. PubMed ID: 15030293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-lowering study raises issues of therapy's value.
    Thompson CA
    Am J Health Syst Pharm; 2008 Apr; 65(7):594-5. PubMed ID: 18359962
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ezetimibe--a new approach in hypercholesterolemia management.
    Suchy D; Łabuzek K; Stadnicki A; Okopień B
    Pharmacol Rep; 2011; 63(6):1335-48. PubMed ID: 22358082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Ueda S; Fukami K; Okuda S; Yamagishi S
    Pharmacol Res; 2010 Jan; 61(1):58-61. PubMed ID: 19666118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.